MedPath

OTULFI

OTULFI

Approved
DIN Number

02554291

Drug Class

Human

Market Date

Apr 15, 2025

Company
HC

fresenius kabi canada ltd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02554291
AIG Number0152506001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L04AC05 USTEKINUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.20.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

USTEKINUMABActive
Strength: 90 MG / ML
Monograph: USTEKINUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.